期刊文献+

标本存放温度和时间对血浆中抗凝蛋白活性的影响 被引量:4

Influence of storage time and temperature on plasma anticoagulation protein activity
下载PDF
导出
摘要 目的探讨标本存放温度和时间对血浆中抗凝蛋白活性的影响。方法用真空采血管采集住院患者空腹静脉血20例,无黄疸、脂血、溶血,即刻以3 000r/min离心10min,上机测得的结果与在室温(20~25℃)、4℃和-20℃放置4h、12h、24h、7d、14d的血浆标本测得的结果分别进行比较。结果在室温下保存ATⅢ、PC活性24h内均无明显变化,仅PS活性明显降低,7d和14d时检测抗凝蛋白活性均明显降低(P〈0.05);在4℃放置7dATⅢ、PC活性有所降低,但与即时活性相比差异无统计学意义,而PS活性明显下降(P〈0.05),14d时三者活性均明显下降(P〈0.05);在-20℃保存14d甚至更长时间抗凝蛋白活性均无明显降低。结论为保证抗凝蛋白活性,血液标本应置于低温保存并尽快检测。 Objective To investigate the influence of storage time and temperature on anticoagulation protein activity in plasma .Methods Fasting venous blood was collected from 20 inpatients without jaundice ,lipidemia and hemolysis by vacutainer ,immediately centrifuged by 3 000 r/min for 10 min and detected .The detected results were compared with those stored in the room temperature(20-25 ℃) ,at 4 ℃ and -20 ℃ ,for 4 h ,12 h ,24 h ,7 d ,14 d respectively .Results The ATⅢ and PC activity of the sample stored in the room temperature within 24 h had no significant change ,but only the PS activity was significantly decreased ,the anticoagulation protein activity detected on 7 ,14 d was significantly decreased(P〈0 .05);the ATⅢ and PC activity of the sample stored at 4 ℃ for 7 d was de‐creased ,but the difference had no statistical significance compared with those of immediately detected samples ,but the PS activity was significantly decreased(P〈 0 .05) ,the activity of 3 indexes on 14 d was decreased significantly (P〈0 .05);the activity of anticoagulation protein of the sample stored at -20 ℃ for 14 d or even longer time had no obvious decrease .Conclusion The blood samples should be placed in the low temperature and detected as soon as possible for ensuring the anticoagulant protein activity .
作者 李蕾 王培昌
出处 《检验医学与临床》 CAS 2015年第17期2533-2534,共2页 Laboratory Medicine and Clinic
关键词 抗凝蛋白 抗凝血酶Ⅲ 蛋白C 蛋白S 温度 时间 anticoagulation proteinl antithrombinⅢ protein C protein S temperature time
  • 相关文献

参考文献10

  • 1Hepner M, Karlaftis V. Antilhrombin[J]. Mathods Mol Boil,2013,992(8) :355 -364.
  • 2Shen L,Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C m degradation of factor Ⅷ α[J]. J Biol Chem, 1994,269(29) : 18735- 18738.
  • 3De Stefano V,Simioni P,Rossi E,el al. The risk ofrecur rent venous thromboembolism in patients with inheriled deficiency of natural anticoagulants antlthrombin, protein C and protein S[J]. Haematologica,2006,91 (5) :695 -698.
  • 4白春梅,潘家绮,范连凯,王书杰.静脉血栓患者抗凝蛋白缺陷研究[J].中华内科杂志,2000,39(11):746-748. 被引量:20
  • 5Shen MC,Lin JS,Tsay W. High prevalence of antithrom- bin Ⅲ , protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan[J]. Thromb Res, 1997,87 (4) : 377-385.
  • 6Liu HW, Kwong YL, Bourke C, et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis[J]. Thromb Haemost,1994,71(4) :416-419.
  • 7Chen TY, Su WC,Tsao CJ. Incidence of thrombophilia de- tected in southern Taiwan Residents patients with venous throm- bosis[J]. Ann Hematol,2003,82(2) : 114-117.
  • 8秦小玉,宋燕,陈宁恒,王汉杰,苗仁英,刘晋阳.静脉血栓栓塞症患者血清AT3、蛋白C、蛋白S水平临床分析[J].中国医药科学,2014,4(1):12-14. 被引量:10
  • 9丛玉隆.关于卫生部出凝血时间操作规程《通知》的理解[J].中华检验医学杂志,2001,24(3):183-185. 被引量:65
  • 10卜国平,曹伟建.凝血实验的影响因素探讨[J].江西医学检验,2005,23(4):353-354. 被引量:12

二级参考文献23

  • 1Shen M C,Thromb Res,1997年,87卷,377页
  • 2Liu H W,Thromb Haemost,1994年,71卷,416页
  • 3Cohen AT, Agnelli G, Anderson FA, et al.Venous thromboembolism ( VTE ) in Europe. The number of VTE events and associated morbidity and mortality[J].Thromb Haemost, 2007,98 ( 4 ) : 756-764.
  • 4Zakai NA, Mcclure LA.Racial differences in venous thromboembolism[J].J Thromb Haemost,2011,9 ( 10 ): 1877-1882.
  • 5Shen L, Dahlback B.Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa[J].J Biol Chem, 1994,269 ( 29 ): 18735-18738.
  • 6Prandoni P, Lensing A W, Cogo A, et al.The long-term clinical course of acute deep venous thrombosis[J].Ann Intern Med, 1996, 125 ( 1 ) : 1-7.
  • 7Souto JC, Almasy L, Borrell M, et al.Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia[J].Am J Hum Genet, 2000,67 ( 6 ) : 1452- 1459.
  • 8Schafer AI, Levine MN, Konkle BA, et al.Thrombotic disorders: diagnosis and treatment[J],Hematology Am Soc Hematol Educ Program, 2003 : 520-539.
  • 9De Stefano V, Simioni P, Rossi E, et al.The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S[J].Haematologica,2006,91 (5): 695-698.
  • 10Kuhli C, Joehmans K, Scharrer I, et al.Retinal vein occlusion associated with antithrombin deficiency secondary to a novel G9840C missense mutation[J].Arch Ophthalmol, 2006,124 ( 8 ) : 1165-1169.

共引文献102

同被引文献42

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部